<DOC>
	<DOCNO>NCT00534898</DOCNO>
	<brief_summary>Background : In propose study , aim investigate safety efficacy two synthetic retinoids - bexarotene ( Targretin ; LGD1069 ; 4- [ 1- { 5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl } ethenyl ] benzoic acid ) fenretinide ( Dihydroceramide N- ( 4-Hydroxyphenyl retinamide ) severity psychopathology cognitive impairment schizophrenia patient double-blind , placebo-controlled study . The rationale behind add-on medication ongoing antipsychotic treatment schizophrenia patient base retinoid dysregulation hypothesis : growth factor deficiency synaptic destabilization hypothesis schizophrenia . Furthermore , preliminary open clinical trial , find low dose bexarotene ( Targretin , 75 mg/day ) safe lead significant improvement total PANSS score , general psychopathology , positive dysphoric mood factor score . The aim present study provide insight safety efficacy bexarotene comparison fenretinide ( medication small potential adverse effect ) placebo patient suffer schizophrenia .</brief_summary>
	<brief_title>Bexarotene Fenretinide Addition Antipsychotic Treatment Schizophrenia Patients</brief_title>
	<detailed_description>In clinical trial , minimal dose bexarotene ( Targretin , 75 mg/day ) fenretinide 5 mg/day placebo add 8 week stable ongoing antipsychotic treatment 90 schizophrenia patient . Participants assess baseline 2 , 4 8 week treatment . A battery research instrument use assessment efficacy safety ( psychopathology , side effect ) . In addition , cholesterol triglyceride level , liver thyroid function test blood cell count monitor baseline therapy .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Bexarotene</mesh_term>
	<criteria>1 . Age 1860 year , male female 2 . DSMIV criterion schizophrenia 3 . Ability willingness sign inform consent participation study 4 . Stable blood parameter 5 . Only patient normal baseline fast triglyceride Exclusion criterion : 1 . Lipid abnormality . 2 . Leukopenia neutropenia . 3 . Evidence organic brain damage , mental retardation , alcohol drug abuse 4 . Renal disease 5 . Hepatic dysfunction . 6 . A history pancreatitis . 7 . Thyroid axis alteration 8 . Suicide attempt past year . 9 . Cataracts . 10 . High dose vitamin A daily treatment . 11 . Patients know hypersensitivity bexarotene component product . 12 . Pregnant woman woman intend become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>